In particular, tumor-related platelet activation by downregulation of RGS18 and an immune suppression by upregulation of both SNORA12 and SNORD97 may be essential mechanisms for cervical cancer development and progression. This evidence concerns the gene SNORD97 and cervical carcinoma.